Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study

BioPsychoSocial Medicine

Volumn 5, Issue , 2011, Pages

  Otani, Makoto ^a,b   Takimoto, Yoshiyuki ^a   Moriya, Junko ^a   Yoshiuchi, Kazuhiro ^a   Akabayashi, Akira ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kanto Teishin Hospital   (Japan)

Author keywords

1,25 dihydroxyvitamin D (1,25 (OH)2D); Binge eating; Bulimia nervosa (BN); Dietary phosphate plasma phosphate; Fibroblast growth factor 23 (FGF23)intact fibroblast growth factor 23 (iFGF23)eating disorders; Frequency of binge eating

Indexed keywords

EID: 79958799580     PISSN: None     EISSN: 17510759     Source Type: Journal    
DOI: 10.1186/1751-0759-5-7     Document Type: Article

References (13)

1. Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 2003, 285:E1-E9.
2. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004, 9:29-435.
3. Shimada T, Yamazaki Y, Takahashi M, Hasegawa H, Urakawa I, Oshima T, Ono K, Takitani M, Tomizuka K, Fujita T, Fukumoto S, Yamashita T. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 2005, 289:F1088-F1095. 10.1152/ajprenal.00474.2004, 15998839.
4. Weber TJ, Liu S, Indridason OS, Quarles LD. Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 2003, 18:1227-1234. 10.1359/jbmr.2003.18.7.1227, 12854832.
5. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004, 65:1943-1946. 10.1111/j.1523-1755.2004.00604.x, 15086938.
6. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N. Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 2005, 280:2543-2549.
7. Burnett SM, Gunawardene SC, Bringhurst FR, Jüppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006, 21:1187-1196. 10.1359/jbmr.060507, 16869716.
8. Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 2005, 90:1519-1524.
9. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 1994, Washington DC, 4, American Psychiatric Association.
10. Otani M, Takimoto Y, Moriya J, Yoshiuchi K, Akabayashi A. Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa. Biopsychosoc Med 2008, 2(10):1-4. 2248596, 18194547.
11. Tebben PJ, Kalli K, Cliby WA, Hartmann LC, Grande JP, Singh RJ, Kumar R. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc 2005, 80:745-751. 10.4065/80.6.745, 15948297.
12. Park SE, Cho MA, Kim SH, Rhee Y, Kang ES, Ahn CW, Cha BS, Lee EJ, Kim KR, Lee HC, Lim SK. The adaptation and relationship of FGF-23 to change in mineral metabolism in Grave's disease. Clin Endcrinol 2007, 66:854-858.
13. Gwirtsman HE, Kaye WH, George DT, Carosella NW, Greene RC, Jimerson DC. Hyperamylasemia and its relationship to binge-purge episodes: development of a clinically relevant laboratory test. J Clin Psychiatry 1989, 50:196-204.